Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Times Interest Earned (2021 - 2025)

Regenxbio has reported Times Interest Earned over the past 7 years, most recently at -$4.7 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$4.7 for Q4 2025, up 13.93% from a year ago — trailing twelve months through Dec 2025 was -$3.58 (up 80.57% YoY), and the annual figure for FY2025 was -$3.58, up 80.57%.
  • Times Interest Earned for Q4 2025 was -$4.7 at Regenxbio, down from -$3.98 in the prior quarter.
  • Over the last five years, Times Interest Earned for RGNX hit a ceiling of $48.25 in Q4 2021 and a floor of -$124.8 in Q2 2024.
  • Median Times Interest Earned over the past 5 years was -$10.39 (2022), compared with a mean of -$22.44.
  • Biggest five-year swings in Times Interest Earned: plummeted 616.08% in 2023 and later soared 104.37% in 2025.
  • Regenxbio's Times Interest Earned stood at $48.25 in 2021, then tumbled by 127.78% to -$13.4 in 2022, then plummeted by 249.78% to -$46.88 in 2023, then soared by 88.37% to -$5.45 in 2024, then grew by 13.93% to -$4.7 in 2025.
  • The last three reported values for Times Interest Earned were -$4.7 (Q4 2025), -$3.98 (Q3 2025), and -$5.76 (Q2 2025) per Business Quant data.